13 results on '"Ahmed, Zubair"'
Search Results
2. Overexpression of Reticulon 3 Enhances CNS Axon Regeneration and Functional Recovery after Traumatic Injury.
- Author
-
Alhajlah S, Thompson AM, and Ahmed Z
- Subjects
- Animals, Axons pathology, Behavior, Animal, Carrier Proteins genetics, Cells, Cultured, Disease Models, Animal, Female, Ganglia, Spinal pathology, Motor Activity, Optic Nerve Injuries genetics, Optic Nerve Injuries pathology, Optic Nerve Injuries physiopathology, Rats, Sprague-Dawley, Retinal Ganglion Cells pathology, Signal Transduction, Spinal Cord Injuries genetics, Spinal Cord Injuries pathology, Spinal Cord Injuries physiopathology, Up-Regulation, Vesicular Transport Proteins genetics, Vesicular Transport Proteins metabolism, Rats, Axons metabolism, Carrier Proteins metabolism, Ganglia, Spinal metabolism, Nerve Regeneration, Neuronal Outgrowth, Optic Nerve Injuries metabolism, Retinal Ganglion Cells metabolism, Spinal Cord Injuries metabolism
- Abstract
CNS neurons are generally incapable of regenerating their axons after injury due to several intrinsic and extrinsic factors, including the presence of axon growth inhibitory molecules. One such potent inhibitor of CNS axon regeneration is Reticulon (RTN) 4 or Nogo-A. Here, we focused on RTN3 as its contribution to CNS axon regeneration is currently unknown. We found that RTN3 expression correlated with an axon regenerative phenotype in dorsal root ganglion neurons (DRGN) after injury to the dorsal columns, a well-characterised model of spinal cord injury. Overexpression of RTN3 promoted disinhibited DRGN neurite outgrowth in vitro and dorsal column axon regeneration/sprouting and electrophysiological, sensory and locomotor functional recovery after injury in vivo. Knockdown of protrudin, however, ablated RTN3-enhanced neurite outgrowth/axon regeneration in vitro and in vivo. Moreover, overexpression of RTN3 in a second model of CNS injury, the optic nerve crush injury model, enhanced retinal ganglion cell (RGC) survival, disinhibited neurite outgrowth in vitro and survival and axon regeneration in vivo, an effect that was also dependent on protrudin. These results demonstrate that RTN3 enhances neurite outgrowth/axon regeneration in a protrudin-dependent manner after both spinal cord and optic nerve injury.
- Published
- 2021
- Full Text
- View/download PDF
3. Retinal Ganglion Cell Survival and Axon Regeneration after Optic Nerve Transection is Driven by Cellular Intravitreal Sciatic Nerve Grafts.
- Author
-
Ahmed Z, Suggate EL, Logan A, and Berry M
- Subjects
- Animals, Astrocytes pathology, Cell Survival, Ependymoglial Cells pathology, Intravitreal Injections, Ligands, Macrophage Activation, Macrophages pathology, Male, Rats, Inbred F344, Receptors, Nerve Growth Factor metabolism, rho GTP-Binding Proteins metabolism, Axons pathology, Nerve Regeneration, Optic Nerve Injuries pathology, Retinal Ganglion Cells pathology, Sciatic Nerve transplantation
- Abstract
Neurotrophic factors (NTF) secreted by Schwann cells in a sciatic nerve (SN) graft promote retinal ganglion cell (RGC) axon regeneration after either transplantation into the vitreous body of the eye or anastomosis to the distal stump of a transected optic nerve. In this study, we investigated the neuroprotective and growth stimulatory properties of SN grafts in which Schwann cells had been killed (acellular SN grafts, ASN) or remained intact (cellular SN grafts, CSN). We report that both intravitreal ( ivit ) implanted and optic nerve anastomosed CSN promote RGC survival and when simultaneously placed in both sites, they exert additive RGC neuroprotection. CSN and ASN were rich in myelin-associated glycoprotein (MAG) and axon growth-inhibitory ligand common to both the central nervous system (CNS) and peripheral nervous system (PNS) myelin. The penetration of the few RGC axons regenerating into an ASN at an optic nerve transection (ONT) site is limited into the proximal perilesion area, but is increased >2-fold after ivit CSN implantation and increased 5-fold into a CSN optic nerve graft after ivit CSN implantation, potentiated by growth disinhibition through the regulated intramembranous proteolysis (RIP) of p75
NTR (the signalling trans-membrane moiety of the nogo-66 trimeric receptor that binds MAG and associated suppression of RhoGTP). Mϋller cells/astrocytes become reactive after all treatments and maximally after simultaneous ivit and optic nerve CSN/ASN grafting. We conclude that simultaneous ivit CSN plus optic nerve CSN support promotes significant RGC survival and axon regeneration into CSN optic nerve grafts, despite being rich in axon growth inhibitory molecules. RGC axon regeneration is probably facilitated through RIP of p75NTR , which blinds axons to myelin-derived axon growth-inhibitory ligands present in optic nerve grafts., Competing Interests: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.- Published
- 2020
- Full Text
- View/download PDF
4. Pigment Epithelium-Derived Factor Promotes Axon Regeneration and Functional Recovery After Spinal Cord Injury.
- Author
-
Stevens AR, Ahmed U, Vigneswara V, and Ahmed Z
- Subjects
- Animals, Axons drug effects, Cell Survival drug effects, Disease Models, Animal, Female, Ganglia, Spinal drug effects, Ganglia, Spinal metabolism, Nerve Growth Factors metabolism, Neurites drug effects, Neurites metabolism, Neuroprotection drug effects, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Sprague-Dawley, Receptors, Nerve Growth Factor metabolism, Sciatic Nerve drug effects, Sciatic Nerve physiopathology, Signal Transduction drug effects, Spinal Cord Injuries pathology, Up-Regulation drug effects, Axons physiology, Eye Proteins pharmacology, Nerve Growth Factors pharmacology, Nerve Regeneration drug effects, Recovery of Function drug effects, Serpins pharmacology, Spinal Cord Injuries physiopathology
- Abstract
Although neurons in the adult mammalian CNS are inherently incapable of regeneration after injury, we previously showed that exogenous delivery of pigment epithelium-derived factor (PEDF), a 50-kDa neurotrophic factor (NTF), promoted adult retinal ganglion cell neuroprotection and axon regeneration. Here, we show that PEDF and other elements of the PEDF pathway are highly upregulated in dorsal root ganglion neurons (DRGN) from regenerating dorsal column (DC) injury paradigms when compared with non-regenerating DC injury models. Exogenous PEDF was neuroprotective to adult DRGN and disinhibited neurite outgrowth, whilst overexpression of PEDF after DC injury in vivo promoted significant DC axon regeneration with enhanced electrophysiological, sensory, and locomotor function. Our findings reveal that PEDF is a novel NTF for adult DRGN and may represent a therapeutically useful factor to promote functional recovery after spinal cord injury.
- Published
- 2019
- Full Text
- View/download PDF
5. BMP4/Smad1 Signalling Promotes Spinal Dorsal Column Axon Regeneration and Functional Recovery After Injury.
- Author
-
Farrukh F, Davies E, Berry M, Logan A, and Ahmed Z
- Subjects
- Animals, Carrier Proteins metabolism, Dependovirus metabolism, Female, Ganglia, Spinal metabolism, Neuronal Outgrowth, Rats, Sprague-Dawley, TOR Serine-Threonine Kinases metabolism, Axons physiology, Bone Morphogenetic Protein 4 metabolism, Nerve Regeneration physiology, Recovery of Function, Signal Transduction, Smad1 Protein metabolism, Spinal Cord Injuries metabolism, Spinal Cord Injuries physiopathology
- Abstract
Signalling through the BMP4/Smad1 pathway promotes corticospinal tract axon regeneration and functional recovery in mice. However, unlike humans and rats, mice do not cavitate. Here, we investigated if activation of the BMP4/Smad1 pathway promotes axon regeneration and functional recovery in a rat model that cavitates. We show that dorsal root ganglion neurons (DRGN) in injury models, including the non-regenerating dorsal column (DC) and the regenerating sciatic nerve (SN) crush and preconditioning (p) SN + DC (pSN + DC) paradigms, regulate the BMP4/Smad1 signalling pathway. For example, mRNA expression of positive regulators of the BMP4/Smad1 pathway was highly up-regulated whilst negative regulators were significantly down-regulated in DRGN in the regenerating SN and pSN + DC models compared to non-regenerating DC models, matched by concomitant changes in protein expression detected in DRGN by immunohistochemistry. BMP4 peptide promoted significant DRGN survival and disinhibited neurite outgrowth in vitro, whilst AAV-BMP4 delivery in vivo stimulated DC axon regeneration and functional recovery in a model that cavitates. Our results show that activation of the BMP4/Smad1 pathway is a potential therapeutic target in the search for axon regenerative signalling pathways in the CNS.
- Published
- 2019
- Full Text
- View/download PDF
6. Effects of siRNA-Mediated Knockdown of GSK3β on Retinal Ganglion Cell Survival and Neurite/Axon Growth.
- Author
-
Ahmed Z, Morgan-Warren PJ, Berry M, Scott RAH, and Logan A
- Subjects
- Animals, Male, Rats, Rats, Sprague-Dawley, Axons metabolism, Glycogen Synthase Kinase 3 beta deficiency, Glycogen Synthase Kinase 3 beta genetics, Neurites metabolism, RNA, Small Interfering genetics, Retinal Ganglion Cells cytology
- Abstract
There are contradictory reports on the role of the serine/threonine kinase isoform glycogen synthase kinase-3β (GSK3β) after injury to the central nervous system (CNS). Some report that GSK3 activity promotes axonal growth or myelin disinhibition, whilst others report that GSK3 activity prevents axon regeneration. In this study, we sought to clarify if suppression of GSK3β alone and in combination with the cellular-stress-induced factor RTP801 (also known as REDD1: regulated in development and DNA damage response protein), using translationally relevant siRNAs, promotes retinal ganglion cell (RGC) survival and neurite outgrowth/axon regeneration. Adult mixed retinal cell cultures, prepared from rats at five days after optic nerve crush (ONC) to activate retinal glia, were treated with siRNA to GSK3β (siGSK3β) alone or in combination with siRTP801 and RGC survival and neurite outgrowth were quantified in the presence and absence of Rapamycin or inhibitory Nogo-A peptides. In in vivo experiments, either siGSK3β alone or in combination with siRTP801 were intravitreally injected every eight days after ONC and RGC survival and axon regeneration was assessed at 24 days. Optimal doses of siGSK3β alone promoted significant RGC survival, increasing the number of RGC with neurites without affecting neurite length, an effect that was sensitive to Rapamycin. In addition, knockdown of GSK3β overcame Nogo-A-mediated neurite growth inhibition. Knockdown of GSK3β after ONC in vivo enhanced RGC survival but not axon number or length, without potentiating glial activation. Knockdown of RTP801 increased both RGC survival and axon regeneration, whilst the combined knockdown of GSK3β and RTP801 significantly increased RGC survival, neurite outgrowth, and axon regeneration over and above that observed for siGSK3β or siRTP801 alone. These results suggest that GSK3β suppression promotes RGC survival and axon initiation whilst, when in combination with RTP801, it also enhanced disinhibited axon elongation., Competing Interests: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
- Published
- 2019
- Full Text
- View/download PDF
7. Return of function after CNS axon regeneration: Lessons from injury-responsive intrinsically photosensitive and alpha retinal ganglion cells.
- Author
-
Berry M, Ahmed Z, and Logan A
- Subjects
- Animals, Crush Injuries, Disease Models, Animal, Myelin Sheath, Optic Nerve Injuries metabolism, Recovery of Function physiology, Axons physiology, Nerve Regeneration physiology, Optic Nerve Injuries physiopathology, Retinal Ganglion Cells physiology
- Abstract
This review addresses issues relating to the survival and axon regeneration of both intrinsically photosensitive retinal ganglion cells (ipRGC) and αRGC, and possible ensuing patterns of functional recovery after optic nerve crush, all of which are broadly relevant to recovery from injury in the central nervous system (CNS) as whole. Although much needs to be clarified about the connectivity, function and patterns of myelination of regenerated CNS axons, the results of recent research on activity-induced αRGC axon regeneration associated with functional restitution have highlighted key focal obstacles to recovery including neurotrophic support, axon misguidance, target recognition failure and dysmyelination. Pan RGC survival/axon regeneration requires receptor binding and downstream signalling by a cocktail of growth factors, more generally defined in the CNS by the individual trophic requirements of neuronal subsets within a given disconnected centre. Resolution of the problem of failed axon guidance and target recognition is complicated by a confounding paradox that axon growth inhibitory ligand disinhibition required for axon regeneration may mask axon guidance cues that are essential for accurate re-innervation. The study of the temporal parameters of remyelination of regenerated αRGC axons may become feasible if they establish permanent homologous connections, allowing time for new myelin sheaths to fully form. Unless near complete re-innervation of denervated targets is re-instated in the CNS, debilitating dysfunctional neurological sequelae may ensue from the resulting imbalance in connectivity., (Copyright © 2018. Published by Elsevier Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
8. Activation of the BMP4/Smad1 Pathway Promotes Retinal Ganglion Cell Survival and Axon Regeneration.
- Author
-
Thompson A, Berry M, Logan A, and Ahmed Z
- Subjects
- Animals, Bone Morphogenetic Protein 4 pharmacology, Cell Survival physiology, Cells, Cultured, Female, Immunohistochemistry, Nerve Crush, Optic Nerve Injuries physiopathology, RNA, Messenger genetics, RNA, Small Interfering, Rats, Rats, Inbred F344, Rats, Sprague-Dawley, Real-Time Polymerase Chain Reaction, TOR Serine-Threonine Kinases metabolism, Axons physiology, Bone Morphogenetic Protein 4 metabolism, Nerve Regeneration physiology, Retinal Ganglion Cells physiology, Signal Transduction physiology, Smad1 Protein metabolism
- Abstract
Purpose: We investigate if the BMP4/Smad1 intracellular signaling pathway is neuroprotective and axogenic in adult rodent retinal ganglion cells (RGC) in vivo and in vitro., Methods: Adult retinal cultures were prepared from intact and after optic nerve crush (ONC) injured rats that have been stimulated to survive and regenerate using an intravitreal peripheral nerve (PN) graft. Laser capture microdissection (LCM) then was used to isolate RGC with and without neurites. Quantitative RT-PCR determined changes in BMP4/Smad1 signaling pathway mRNA. Immunohistochemistry confirmed localization of BMP4 and activation of Smad1 in ONC+PN-stimulated RGC in vivo. BMP4 peptide was used to stimulate RGC survival and neurite/axon regeneration in vitro and in vivo. Finally, the rapamycin sensitivity of the effects was determined in BMP4-stimulated RGC in vitro and in vivo., Results: In retinal cultures prepared from intact and ONC+PN-stimulated rats, RGC with neurites had upregulated regeneration-related and BMP4/Smad1 signaling pathway mRNA levels, while low levels of these mRNAs were present in RGC isolated without neurites. An optimal dose of 200 ng/mL BMP4 peptide in vitro promoted approximately 30% RGC survival and disinhibited RGC neurite outgrowth, despite the presence of inhibitory CNS myelin extracts. BMP4 also promoted approximately 30% RGC survival in vivo and stimulated significant RGC axon regeneration at 100, 200, and 400 μm beyond the lesion site. Finally, the response of RGC to BMP4 treatment in vitro and in vivo was rapamycin-insensitive., Conclusions: Activation of the BMP4/Smad1 pathway promotes survival and axon regeneration independent of mTOR and, therefore, may be of therapeutic interest.
- Published
- 2019
- Full Text
- View/download PDF
9. siRNA-Mediated Knockdown of the mTOR Inhibitor RTP801 Promotes Retinal Ganglion Cell Survival and Axon Elongation by Direct and Indirect Mechanisms.
- Author
-
Morgan-Warren PJ, O'Neill J, de Cogan F, Spivak I, Ashush H, Kalinski H, Ahmed Z, Berry M, Feinstein E, Scott RA, and Logan A
- Subjects
- Animals, Cell Survival physiology, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Gene Knockdown Techniques, Immunohistochemistry, Immunosuppressive Agents pharmacology, Intravitreal Injections, Male, Nerve Crush, Nerve Growth Factors metabolism, Optic Nerve Injuries etiology, Optic Nerve Injuries prevention & control, Rats, Rats, Wistar, Retinal Ganglion Cells metabolism, Sirolimus pharmacology, TOR Serine-Threonine Kinases metabolism, Transcription Factors, Transfection, Axons physiology, Gene Expression Regulation physiology, Nerve Regeneration physiology, RNA, Small Interfering pharmacology, Repressor Proteins genetics, Retinal Ganglion Cells cytology, TOR Serine-Threonine Kinases antagonists & inhibitors
- Abstract
Purpose: To investigate, using in vivo and in vitro models, retinal ganglion cell (RGC) neuroprotective and axon regenerative effects and underlying mechanisms of siRTP801, a translatable small-interfering RNA (siRNA) targeting the mTOR negative regulator RTP801., Methods: Adult rats underwent optic nerve (ON) crush (ONC) followed by intravitreal siRTP801 or control siRNA (siEGFP) every 8 days, with Brn3a+ RGC survival, GFAP+ reactive gliosis, and GAP43+ regenerating axons analyzed immunohistochemically 24 days after injury. Retinal cultures, prepared from uninjured animals or 5 days after ONC to activate retinal glia, were treated with siRTP801/controls in the presence/absence of rapamycin and subsequently assessed for RGC survival and neurite outgrowth, RTP801 expression, glial responses, and mTOR activity. Conditioned medium was analyzed for neurotrophin titers by ELISA., Results: Intravitreal siRTP801 enabled 82% RGC survival compared to 45% with siEGFP 24 days after ONC, correlated with greater GAP43+ axon regeneration at 400 to 1200 μm beyond the ONC site, and potentiated the reactive GFAP+ Müller glial response. In culture, siRTP801 had a direct RGC neuroprotective effect, but required GFAP+ activated glia to stimulate neurite elongation. The siRTP801-induced neuroprotection was significantly reduced, but not abolished, by rapamycin. The siRTP801 potentiated the production and release of neurotrophins NGF, NT-3, and BDNF, and prevented downregulation of RGC mTOR activity., Conclusions: The RTP801 knockdown promoted RGC survival and axon elongation after ONC, without increasing de novo regenerative sprouting. The neuroprotection was predominantly direct, with mTORC1-dependent and -independent components. Enhanced neurite/axon elongation by siRTP801 required the presence of activated retinal glia and was mediated by potentiated secretion of neurotrophic factors.
- Published
- 2016
- Full Text
- View/download PDF
10. Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration.
- Author
-
Vigneswara V, Esmaeili M, Deer L, Berry M, Logan A, and Ahmed Z
- Subjects
- Analysis of Variance, Animals, Axons physiology, Disease Models, Animal, Dose-Response Relationship, Drug, Eye Proteins metabolism, Female, GAP-43 Protein metabolism, In Vitro Techniques, Intravitreal Injections, Nerve Growth Factors metabolism, Ophthalmic Solutions therapeutic use, Optic Nerve Injuries drug therapy, Rats, Rats, Sprague-Dawley, Retina cytology, Serpins metabolism, Tubulin metabolism, Axons drug effects, Eye Proteins pharmacology, Nerve Growth Factors pharmacology, Nerve Regeneration drug effects, Neuroprotective Agents pharmacology, Retinal Ganglion Cells drug effects, Serpins pharmacology
- Abstract
Axotomised retinal ganglion cells (RGCs) die rapidly by apoptosis and fail to regenerate because of the limited availability of neurotrophic factors and a lack of axogenic stimuli. However, we have recently showed that pigment epithelium-derived factor (PEDF) promotes RGC survival and axon regeneration after optic nerve crush injury. PEDF has multiple fragments of the native peptide that are neuroprotective, anti-angiogenic and anti-inflammatory. Here we investigated the neuroprotective and axogenic properties of a fragment of PEDF, PEDF-34, in retinal neurons in vitro and when delivered by intravitreal injection and eye drops in vivo. We found that PEDF-34 was 43% more neuroprotective and 52% more neuritogenic than PEDF-44 in vitro. Moreover, in vivo, intravitreal delivery of 1.88nM PEDF-34 was 71% RGC neuroprotective at 21days after optic nerve crush compared to intact controls, whilst daily eye drops containing 1.88nM PEDF-34 promoted 87% RGC survival. After topical eye drop delivery, PEDF-34 was detected in the vitreous body within 30min and attained physiologically relevant concentrations in the retina by 4h peaking at 1.4±0.05nM by 14days. In eye drop- compared to intravitreal-treated PEDF-34 animals, 55% more RGC axons regenerated 250μm beyond the optic nerve lesion. We conclude that daily topical eye drop application of PEDF-34 is superior to weekly intravitreal injections in promoting RGC survival and axon regeneration through both direct effects on retinal neurons and indirect effects on other retinal cells., (Copyright © 2015. Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF
11. Prospects for mTOR-mediated functional repair after central nervous system trauma.
- Author
-
Berry, Martin, Ahmed, Zubair, Morgan-Warren, Peter, Fulton, Daniel, and Logan, Ann
- Subjects
- *
MTOR protein , *DEVELOPMENTAL neurobiology , *CELLULAR signal transduction , *PROTEIN kinase B , *AXONS , *NERVOUS system regeneration , *SPINAL cord injuries - Abstract
Recent research has suggested that the growth of central nervous system (CNS) axons during development is mediated through the PI3K/Akt/mammalian target of rapamycin (mTOR) intracellular signalling axis and that suppression of activity in this pathway occurs during maturity as levels of the phosphatase and tensin homologue (PTEN) rise and inhibit PI3K activation of mTOR, accounting for the failure of axon regeneration in the injured adult CNS. This hypothesis is supported by findings confirming that suppression of PTEN in experimental adult animals promotes impressive axon regeneration in the injured visual and corticospinal motor systems. This review focuses on these recent developments, discussing the therapeutic potential of a mTOR-based treatment aimed at promoting functional recovery in CNS trauma patients, recognising that to fulfil this ambition, the new therapy should aim to promote not only axon regeneration but also remyelination of regenerated axons, neuronal survival and re-innervation of denervated targets through accurate axonal guidance and synaptogenesis, all with minimal adverse effects. The translational challenges presented by the implementation of this new axogenic therapy are also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury.
- Author
-
Taylor, Matthew J., Thompson, Adam M., Alhajlah, Sharif, Tuxworth, Richard I., and Ahmed, Zubair
- Subjects
- *
AXONS , *RETINAL ganglion cells , *CHECKPOINT kinase 2 , *CENTRAL nervous system injuries , *PIGMENT epithelium-derived factor , *CHECKPOINT kinase 1 , *MEDICAL sciences - Abstract
The article discusses a study which showed that targeting of the central ataxia telangiectasia-mutated-checkpoint kinase-2 (ATM-Chk2) pathway regulating the response to double-strand breaks slows neural decline in Drosophila models of chronic neurodegeneration. Results show that Chk2 inhibitor, prexasertib, represents a treatment option to promote functional recovery after spinal cord or optic nerve injury. Also cited are the neuroprotective effects of prexasertib and the experimental design.
- Published
- 2022
- Full Text
- View/download PDF
13. An Ugo1-like protein is associated with optic atrophy ‘plus’ disorders.
- Author
-
Abrams, Alexander J., Hufnagel, Robert B., Rebelo, Adriana, Zanna, Claudia, Patel, Neville, Gonzalez, Michael A., Campeanu, Ion J., Griffin, Laurie B., Groenewald, Saskia, Strickland, Alleene V., Tao, Feifei, Speziani, Fiorella, Caporali, Leonardo, La Morgia, Chiara, Liguori, Rocco, Lodi, Raffaele, Ahmed, Zubair M., Sund, Kristen L., Wang, Xinjian, and Krueger, Laura A.
- Subjects
- *
ATROPHY , *AXONS , *GENETIC mutation , *NEUROPATHY , *MITOCHONDRIAL membranes , *NUCLEOTIDE sequence - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.